// App-Quantinova.ai

339 : B‐cell depletion with Rituximab demonstrates excellent laboratory efficacy at 6 months in patients with complicated autoimmune hepatitis

Researchers

Presenter

  • Daniel Schmidt-Martin

Principal Investigators

  • Sophia Than

  • David H. Adams

  • Jennifer Hayden

  • Ye H. Oo

  • Gideon M. Hirschfield

Medical Centers

  • Centre for Liver Research, Institute of Biomedical Research,, University of Birmingham, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Gastroenterology (GU)

Disease

  • Autoimmune hepatitis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved